Learn more
Log in
0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Stage
Employees
Links
Hugh Y. Rienhoff, Jr.
15 members
9 members
5 members
4 members
3 members
Akoya Biosciences
2 followers
Kura Oncology
16 followers
Genesis Therapeutics
1 follower
Assembly Biosciences
9 followers
SpringWorks Therapeutics
Discover companies